FIELD: medicine.
SUBSTANCE: there are disclosed biological medical agents for psoriasis treatment. The invention concerns application L-serine (Ser) and L- isoleucine (Ile) for manufacturing of a pharmaceutical composition for treatment or prevention of psoriasis. Invention also concerns the pharmaceutical composition containing specified amino acids as active components. Preferentially the pharmaceutical composition additionally contains at least one primary microelement chosen from the group including chrome (Cr), tin (Sn), selenium (Se), vanadium (V), tungsten (W), and zinc (Zn), and folic acid.
EFFECT: technical result consists in implementation of specified function.
10 cl, 1 ex
